¨º¡Á¨°3|¨¬¨ª?¨®¦Ì?¨º?2??D|?¨®¨¨??¨°¦Ì?1¡è??¡ã¨¹
Íâó|¡Á¡é2¨¢|¦Ì???|?¡§??




¡¡
ÃÀ¹úHTS ±àÂë(ÃÀ¹úº£¹Ø¹ØË°±àÂë)  
ÇëÊäÈëHTS±àÂëµÄǰ°ë²¿·Ö»òÉÌÆ·ÃèÊöµÄ²¿·ÖÄÚÈÝ(Ó¢ÎÄ)   HTS ÆäËû²éѯ¹¤¾ß
    
¡¡
  19/99         
ÃÀ¹úº£¹Ø¹ØË°±àÂë
HTS ±àÂëºó ׺ ÉÌÆ·ÃèÊö ÊýÁ¿µ¥Î» Íê˰˰ÂÊ
1 2
ͨ³£ ÌØ±ð
2934.10.70004,5-Dichloro-2-n-octyl-4-isothiazolin-3-one; Ethyl 2-(2-aminothiazol-4-yl)-2- hydroxyiminoacetate; Ethyl 2-(2-aminothiazol-4-yl)-2- methoxyiminoacetate; 2-Methyl-4-isothiazolin- 3-one; 2-n-Octyl-4-isothiazolin-3-one; and Thiothiamine hydrochloridekgFree30.5%
2934.20Compounds containing in the structure a benzothiazole ring-system (whether or not hydrogenated), not further fused:
2934.20.0500N-tert-Butyl-2-benzothiazolesulfenamidekg6.5%Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX,P) 0.2¡é/kg + 3.1% (SG)15.4¡é/kg + 52%
2934.20.10002,2'-Dithiobisbenzothiazolekg6.5%Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX,P) 3% (SG)15.4¡é/kg + 57%
2934.20.15002-Mercaptobenzothiazole; and N-(Oxydiethylene)benzothiazole-2-sulfenamidekg6.5%Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX,P) 0.2¡é/kg + 3.1% (SG)15.4¡é/kg + 52%
2934.20.20002-Mercaptobenzothiazole, sodium salt (2-Benzothiazolethiol, sodium salt)kg6.5%Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX,P) 2.8% (SG)15.4¡é/kg + 40%
2934.20.25002-Amino-5,6-dichlorobenzothiazole; 2-(4-Aminophenyl)-6-methylbenzothiazole-7- sulfonic acid; 2-Amino-6-nitrobenzothiazole; and N,N-Dicyclohexyl-2-benzothiazolesulfenamidekgFree15.4¡é/kg + 52%
2934.20.30002-Amino-6-methoxybenzothiazole; 2-Amino-6-methylbenzothiazole; 6-Ethoxy-2-benzothiazolethiol; 3-Methylbenzothiazole-2-hydrazone; and Primuline basekg5.8%Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,L,MA,MX, P,SG)15.4¡é/kg + 39.5%
2934.30Compounds containing in the structure a phenothiazine ring-system (whether or not hydrogenated), not further fused:
2934.30.12002-(Trifluoromethyl)phenothiazinekg6.5%Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX, P,SG)15.4¡é/kg + 45%
2934.30.1800Ethyl (1H-phenothiazin-2,4,1)carbamatekgFree15.4¡é/kg + 52%
2934.99.03002-Acetylbenzo(b)thiophene; 3-Methylene-7-(2-phenoxyacetamido)- cephan-4-carboxylic acid, p-nitrobenzyl ester, 1-oxide; and Naphth[1,2-d]-[1,2,3]-oxadiazole-5-sulfonic acid and its sodium saltkgFree15.4¡é/kg + 52%
2934.99.05005-Amino-3-phenyl-1,2,4-thiadiazole (3-Phenyl-5-amino-1,2,4-thiadiazole); 2-Hydroxybenzoxazole (Benzoxazolone); 4-Phenylmorpholine; 1,9-Thianthrenedicarboxylic acid; and Thioxanthene-9-one (Thioxanthone)kg5.8%Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX, P,SG)15.4¡é/kg + 39.5%
2934.99.09001,2-Benzisothiazolin-3-onekgFree15.4¡é/kg + 40.5%
2934.99.11002-tert-Butyl-4-(2,4-dichloro-5- isopropoxyphenyl)- 2-1,3,4- oxadiazolin-5-one; 3-Isopropyl-1H-2,1,3- benzothiadiazin-4-(3H)-one-2,2- dioxide (Bentazon); and O,O-Diethyl-S-[(6-chloro-2- oxobenzoxazolin-3-yl)methyl]¡é/phosphorodithioate (Phosalone)kg6.5%Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX, P,SG)15.4¡é/kg + 40.5%
2934.99.2000Photographic chemicalskg6.5%Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX, P,SG)15.4¡é/kg + 50%
2934.99.7000Morpholinoethyl chloride hydrochloride; 2-Methyl-2,5-dioxo-1-oxa-2-phospholan; and (6R-trans)-7-Amino-3-methyl-8-oxo-5- thia-1-azabicyclo[4.2.0]-oct-2-ene-2- carboxylic acidkgFree30.5%
2935.00.3300Sulfathiazole and Sulfathiazole, sodiumkgFree15.4¡é/kg + 133%
2936.22.0000Vitamin B1 (Thiamine) and its derivativeskgFree25%
2939.11.0000Concentrates of poppy straw; buprenorphine (INN); codeine, dihydrocodeine (INN), ethylmorphine, etorphine (INN), heroin, hydrocodone (INN), hydromorphone (INN), morphine, nicomorphine (INN), oxycodone (INN), oxymorphone (INN), pholcodine (INN), thebacon (INN) and thebaine; salts thereofkgFree15.4¡é/kg + 50%
2939.43.0000Cathine (INN) and its saltskgFree15.4¡é/kg + 59%
2942.00.0300[2,2'-Thiobis(4-(1,1,3,3-tetramethyl-n-butyl)- phenolato)(2,1)]-O,O',S-(1-butanamine), nickel IIkgFree15.4¡é/kg + 46.5%
3003Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale:
3004.90.9180Antihistamineskg
3006Pharmaceutical goods specified in note 4 to this chapter:

 19/99          

¨¨¨¨??¨®|¨®?:    ÃÀ¹úº£¹Ø±àÂë²éÕÒ     ²éѯÄÚÈÝ:  

¡Á??¨¹¨®??¡ì2¨¦?¡¥:

I want to Post a new feedback